Working to Eradicate Gynecologic Cancers

15
PARP inhibitors as maintenance therapy for patients with platinum-sensitive recurrent ovarian cancer: can we afford it?

Saturday, March 28, 2015: 2:43 PM
International Ballroom (Hilton Chicago)
H. J. Smith, C. L. Walters Haygood, R. C. Arend, C. A. Leath III and J. M. Straughn Jr.
University of Alabama at Birmingham, Birmingham, AL